PanTheryx Inc., a Boulder life science company that created an infectious diarrhea product, said it's entered into a $53 million financing deal.
The company said it's entered into the $53 million financing with Pegasus Capital Advisors L.P., a Connecticut private equity firm.
PanTheryx said it will use the proceeds "to support the global commercial launch of its infectious diarrhea product, DiaResQ, to aggressively drive its ongoing research and development program, and for other strategic initiatives including acquisitions." DiaResQ, PanTheryx said, "addresses acute infectious diarrhea, a leading cause of death worldwide among children under the age of 5."
Read more at the Denver Business Journal: http://bit.ly/1MTfnAv
(© 2016 American City Business Journals. All rights reserved.)